Embecta Corp.
NASDAQ:EMBCDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $345.06M
- Beta
- 0.81
- P/E (TTM)
- 1.6
- EPS (TTM)
- $1.92
- Dividend yield
- 14.79%
Volume 0.72M
Average 1.95M
EMBC Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Embecta Corp.NASDAQ: EMBC
Other Working Capital · Q2 FY2026 · quarter ended Mar 2026
Other working capital declines year over year
Q2 FY2026 other working capital of $1.7M fell 48.5% year over year, ahead of the -66.2% change in trailing-twelve-month other working capital.
Context
- Other working capital amounted to 0.7% of revenue in FY2025, down 6.8 pp from a year earlier.
- Other working capital increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -48.5% holds above the trailing-twelve-month pace of -66.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- 7.1M USD
- Year-over-year change
- -91.5%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 7.1M | -91.5% |
| FY2024 | 2024-09-30 | 83.5M | +226.3% |
| FY2023 | 2023-09-30 | (66.1M) | +17.6% |
| FY2022 | 2022-09-30 | (80.2M) | -568.3% |
| FY2021 | 2021-09-30 | (12M) | — |
Other Working Capital vs competitors
How EMBC compares with its peers on the latest reported figures
- EMBC's LTM Mar 2026 other working capital of $5.3M is the 7th largest of the 11 companies compared; the peer median is $1.84M.
- Its year-over-year change of -66.2% is the 7th highest of 11, against a peer median of -15.5%.
- Other working capital amounts to 0.5% of revenue for EMBC, versus a peer median of 3.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $139.85M | +22.2% | +111.2% | 7.4% | |
| LTM Mar 2026 | $73.38M | -319.4% | -36.2% | 112.0% | |
| LTM Jun 2026 | $18.28M | +72.1% | -11.3% | 8.8% | |
| LTM Mar 2026 | $16.5M | -53.1% | -37.3% | 2.0% | |
| LTM Mar 2026 | $14.3M | -91.8% | -42.8% | 2.1% | |
| LTM Jun 2026 | $5.4M | +105.0% | +76.6% | 1.2% | |
| LTM Mar 2026 | $5.3M | -66.2% | — | 0.5% | |
| LTM Mar 2026 | $2.87M | -105.6% | -44.9% | 71.1% | |
| LTM Mar 2026 | $2.36M | +114.8% | -49.7% | 4.7% | |
| LTM Mar 2026 | $1.66M | +149.4% | — | 2.6% | |
| LTM Mar 2026 | $804.27K | -78.2% | -9.0% | 0.9% | |
| Peer median (excluding EMBC) | $1.84M | -15.5% | -36.2% | 3.6% | |
Competitors are the stored peer set for EMBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 415M | 223.6M | 70.4M | 78.3M | 95.4M |
| Depreciation & Amortization | 38M | 31.7M | 32.6M | 36.2M | 40.7M |
| Deferred Income Tax | (2M) | (26.5M) | 14.3M | (70.6M) | 17.6M |
| Stock-Based Compensation | 12.8M | 18.7M | 21.5M | 26.3M | 31.6M |
| Change in Working Capital | (32M) | 92.4M | (80M) | (47.7M) | (23.7M) |
| Accounts Receivables | (32M) | 122.7M | 7M | (174.7M) | 44.2M |
| Inventory | (18M) | (23.4M) | (28.8M) | (16.5M) | (6.1M) |
| Accounts Payables | 30M | 73.3M | 7.9M | 60M | (68.9M) |
| Other Working Capital | (12M) | (80.2M) | (66.1M) | 83.5M | 7.1M |
| Other Non-Cash Items | 24.2M | 72.3M | 8.9M | 13.2M | 30.1M |
| Operating Cash Flow | 456M | 412.2M | 67.7M | 35.7M | 191.7M |
| Capital Expenditures | (39M) | (24M) | (26.5M) | (15.8M) | (9.3M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (39M) | (24M) | (26.5M) | (15.8M) | (9.3M) |
| Debt Repayment | 0 | 1.44B | (10.7M) | (35.9M) | (186M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (3.6M) | (3M) | (5.7M) |
| Dividends Paid | 0 | (8.6M) | (34.4M) | (34.5M) | (35M) |
| Other Financing Activities | (417M) | (1.48B) | 0 | 0 | 0 |
| Financing Cash Flow | (417M) | (48M) | (48.7M) | (73.4M) | (226.7M) |
| Effect of Forex Changes | 0 | (9.3M) | 3.1M | 1.2M | (1.3M) |
| Net Change in Cash | 0 | 330.9M | (4.4M) | (52.3M) | (45.6M) |
| Free Cash Flow | 417M | 388.2M | 41.2M | 19.9M | 182.4M |
Embecta Corp.
NASDAQ:EMBC
Intrinsic Alpha fair value
Locked
Current Price
$6.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.